Lumos Pharma | NLNK - Заемный капитал



Заемный капитал Изменить Дата
Agenus USD 23.6M 448K 2025-09
Alterity Therapeutics Limited AUD 103.21K 73.88K 2023-06
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Capricor Therapeutics USD 3.38M 0 2025-03
Cipla INR 2.98B 454.6M 2025-09
Clal Biotechnology ILS 25.96M 18.48M 2023-12
Compugen USD 0 0 2024-12
CSL USD 10.42B 273M 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Grifols EUR 10.67B 564.4M 2025-09
Incyte USD 30.2M 5.17M 2025-12
Intrexon USD 0 198.67M 2024-06
Merck USD 39.97B 6B 2025-09
Nektar Therapeutics USD 107.51M 10.35M 2024-06
Pfizer USD 57.41B 93M 2025-09
Prothena USD 0 0 2024-12
Sarepta Therapeutics USD 828.97M 206.17M 2025-12